Ian Read is the former Chairman and CEO of the biopharmaceutical company Pfizer. Mr Read created more than $240 billion of shareholder value. He stands for good governance, growth and value creation and the ability to transform companies to become strong and successful market leaders.
Mr Read is presently Chairman of DXC, a board member of Kimberly-Clark Corporation and he serves as an Operating Executive in the Global Healthcare Group for the Carlyle Group. Furthermore he joined the board of directors of Viatris.
Ian Read joined Pfizer in 1978 as an operational auditor. From then until 2010 he worked in various leadership roles with increasing responsibility and successfully developed Pfizer’s Worldwide Biopharmaceutical Businesses. In 2010, he became CEO and in 2011, Chairman of Pfizer and retired from these positions in 2018 and 2019, respectively.